IRB fee schedule for industry–sponsored research
Wayne State University charges for IRB review of research studies supported by industry and for‐profit entities pharmaceutical companies and other. There is no charge for review of non-profit sponsored research, such as NIH sponsored studies.
Investigators submitting industry‐sponsored research protocols are required to include the cost of initial protocol review, continuing review, and sponsored initiated full‐board amendments requiring IRB review in the study budget. Fees for continuing review will be collected annually until a Closure form is received by the IRB office.
The fees are based on the assessment of costs associated with the protocol review by the IRB and are charged for services rendered. Because the IRB commits it full resources to each review, the fees are due in full even if the IRB does not approve the study, participants are never enrolled, a research contract is never executed, or the study is terminated before objectives are reached. IRB fees are non‐refundable.
PH1 submissions: Investigators submitting Phase I research studies are required to include the cost of initial protocol review, continuing review, and full-board and expedited amendments (except personnel changes) requiring IRB review in the study budget. In addition, adverse events/unexpected problem reports/safety oversight and a close out fee will be charged. Fees for continuing review will be collected annually until a Closure form is received by the IRB Administration Office.
Fee rates* for M1, MP2, MP4, and B3 IRBs for the current year
|Initial submission review||$2000|
|Full Board Amendment review||$500|
Fee rates* for PH1 IRB for the current year
|Initial submission review||$3500|
|Full Board Amendment review||$750|
|Expedited Amendment review||$200|
|Adverse Events/Unexpected Problem/Safety Oversight||$500|
|Close out fee||$500|
Fee rates* for commercial IRBs for the current year
|Initial submission review||$750|
*The prevailing indirect cost rate for clinical trials will be billed for industry-sponsored trials in addition to the direct IRB fees listed.